Chapter 1. Preface
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Radiopharmaceutical Market, 2015 - 2021, (USD Billion)
2.2. Radiopharmaceutical : Market snapshot
Chapter 3. Radiopharmaceutical Market: Industry Analysis
3.1. Radiopharmaceutical : Market dynamics
3.2. Value Chain Analysis
3.3. Market Drivers
3.3.1. Growing demand for PET and SPECT radioisotopes
3.3.2. Increasing incidences of cancer and heart diseases
3.4. Restraints
3.4.1. Stringent regulatory guidelines
3.4.2. Shorter half-life of nuclear medicine
3.5. Opportunity
3.5.1. Advancing technologies and ongoing research
3.6. Porters Five Forces Analysis
3.7. Market Attractiveness Analysis
3.7.1. Market attractiveness analysis by type segment
3.7.2. Market attractiveness analysis by application segment
3.7.3. Market attractiveness analysis by regional segment
Chapter 4. Global Radiopharmaceutical Market: Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global radiopharmaceutical market: company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Product Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Product and Regional Expansion
4.3. Price Trend Analysis
4.4. Product Portfolio
4.5. Patent Analysis (2011-2016)
4.5.1. Patent Trend
4.5.2. Patent Share by company
4.5.3. By Region
Chapter 5. Global Radiopharmaceutical Market: Product Overview
5.1. Global radiopharmaceutical market share, by type, 2015 and 2021
5.2. Global diagnostic radiopharmaceutical market, 2015 2021 (USD Billion)
5.3. Global therapeutic radiopharmaceutical market, 2015 - 2021 (USD Billion)
Chapter 6. Global Radiopharmaceutical Market: Application Overview
6.1. Global radiopharmaceutical market share, by application, 2015 and 2021
6.2. Global radiopharmaceutical market for cardiology, 2015 - 2021 (USD Billion)
6.3. Global radiopharmaceutical market for neurology, 2015 - 2021 (USD Billion)
6.4. Global radiopharmaceutical market for oncology, 2015 - 2021 (USD Billion)
6.5. Global radiopharmaceutical market for other, 2015 - 2021 (USD Billion)
Chapter 7. Global Radiopharmaceutical Market: Regional Analysis
7.1. Global radiopharmaceutical market: Regional overview
7.1.1. Global radiopharmaceutical market share, by region, 2015 and 2021
7.2. North America
7.2.1. North America radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.2.2. North America radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.2.3. U.S.
7.2.3.1. U.S. radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.2.3.2. U.S. radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.3. Europe
7.3.1. Europe radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.3.2. Europe radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.3.3. UK
7.3.3.1. UK radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.3.3.2. UK radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.3.4. France
7.3.4.1. France radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.3.4.2. France radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.3.5. Germany
7.3.5.1. Germany radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.3.5.2. Germany radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia-Pacific radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.4.2. Asia-Pacific radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.4.3. China
7.4.3.1. China radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.4.3.2. China radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.4.4. Japan
7.4.4.1. Japan radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.4.4.2. Japan radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.4.5. India
7.4.5.1. India radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.4.5.2. India radiopharmaceutical market revenue, by technology, 2015 2021 (USD Billion)
7.5. Latin America
7.5.1. Latin America radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.5.2. Latin America radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.5.3. Brazil
7.5.3.1. Brazil radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.5.3.2. Brazil radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
7.6. Middle East Africa
7.6.1. Middle East Africa radiopharmaceutical market revenue, by type, 2015 2021 (USD Billion)
7.6.2. Middle East Africa radiopharmaceutical market revenue, by application, 2015 2021 (USD Billion)
Chapter 8. Company Profiles
8.1. Cardinal Health, Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. GE Healthcare
8.2.1. Overview
8.2.2. Financials
8.2.3. Product portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Bracco Imaging S.p.A
8.3.1. Overview
8.3.2. Financials
8.3.3. Product portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Nordion, Inc.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. Advanced Accelerator Applications S.A.
8.5.1. Overview
8.5.2. Financials
8.5.3. Product portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Bayer Healthcare
8.6.1. Overview
8.6.2. Financials
8.6.3. Product portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. Lantheus Medical Imaging, Inc.
8.7.1. Overview
8.7.2. Financials
8.7.3. Product portfolio
8.7.4. Business strategy
8.7.5. Recent developments
Chapter 9. Patents
9.1. U.S. (US Patents)
9.2. Europe (EP documents)
9.3. Japan (Abstracts of Japan)
9.4. Global (WIPO (PCT))
